Step Therapy / Prior Authorization Criteria for Ambien CR (zolpidem extended release), Lunesta (eszopiclone), Rozerem (ramelteon), and Sonata (zaleplon)
TRICARE will NOT cover Ambien CR, Lunesta, Rozerem, or Sonata for new patients—defined as patients who have not filled at least one prescription for a newer sedative hypnotic in the previous 180 days at any DoD Pharmacy point of service—UNLESS the patient meets one of the following criteria:
1. The patient has tried zolpidem IR (Ambien) and had an inadequate response.
2. The patient has tried zolpidem IR (Ambien) and was unable to tolerate it due to adverse effects.
3. Treatment with zolpidem IR (Ambien) is contraindicated for this patient.